Latest Lead News

Magnetic Resources NL’s Feasibility Study confirms a robust standalone development for its Lady Julie Gold Project in Western Australia, projecting over 1 million ounces of gold production across nine years with strong financial returns.

Miramar Resources has announced a $1 million Share Purchase Plan to fast-track drilling at its promising 8 Mile gold prospect near Kalgoorlie, following recent significant mineralisation discoveries.

Condor Energy has secured a 12-month extension for its Technical Evaluation Agreement in Peru’s Tumbes Basin, underpinning its exploration and commercialisation plans backed by significant prospective oil and gas resources.

Bastion Minerals and former advisor GTT Ventures have resolved their legal dispute, leading to the withdrawal of a writ that had cast uncertainty over the company.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase to $204 million in Q2 2025, launched its new prostate cancer imaging agent Gozellix in the U.S., and advanced key clinical trials despite an ongoing SEC inquiry.

Adherium Limited has appointed seasoned medtech executive Dawn Bitz as CEO to spearhead the expansion of its Hailie® respiratory monitoring platform, with a strong focus on the US market.

Amotiv Limited reports a slight decline in EBITA for FY25 alongside a significant non-cash impairment on its APG business, reflecting a cautious outlook amid challenging market conditions.

Southern Hemisphere Mining has secured a $13 million farm-in deal with FMR Resources to drill its highly prospective Curiosity copper-gold target in Chile, while also expanding its footprint with new exploration licenses in Western Australia.

MOVE Logistics Group has achieved its FY25 financial targets, showcasing significant improvements in earnings and operational efficiency despite a tough economic backdrop in New Zealand.

Norwest Minerals has reported a substantial 33% increase in its Bulgera Gold Project resource to 288,400 ounces and secured $4.85 million to advance exploration, including a new drilling campaign targeting deeper gold zones.

InhaleRx Limited has secured key ethics approvals and initiated manufacturing for its inhaled drug candidates targeting breakthrough cancer pain and panic disorder, supported by a $38.5 million funding facility to accelerate development.

WAM Global Limited outperformed the MSCI World Index with a 19.4% portfolio gain in FY2025, prompting an increased fully franked dividend of 17.0 cents per share. The company’s strong results reflect strategic positioning amid global market volatility.